Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares (XNDU) had the best week this year by a US stock with a market cap of $2B+ the week of April 13, 2026, returning 221.6%.
| ASSET | WEEK | % RETURN |
|---|---|---|
Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares (XNDU) | 4/13/2026 - 4/19/2026 | 221.62% |
P3 Health Partners (PIII) | 5/11/2026 - 5/17/2026 | 204.31% |
Immunitybio (IBRX) | 1/12/2026 - 1/18/2026 | 135.9% |
MaxLinear (MXL) | 4/20/2026 - 4/26/2026 | 127.62% |
Alumis (ALMS) | 1/5/2026 - 1/11/2026 | 119.78% |
Fluence Energy (FLNC) | 5/4/2026 - 5/10/2026 | 101.33% |
Crinetics Pharmaceuticals (CRNX) | 7/6/2026 - 7/12/2026 | 98.86% |
Nektar Therapeutics (NKTR) | 2/9/2026 - 2/15/2026 | 93.41% |
Innodata (INOD) | 5/4/2026 - 5/10/2026 | 91.19% |
Regencell Bioscience (RGC) | 1/5/2026 - 1/11/2026 | 89.45% |
Erasca (ERAS) | 1/5/2026 - 1/11/2026 | 89.36% |
Hemab Therapeutics Holdings, Inc Common Stock (COAG) | 4/27/2026 - 5/3/2026 | 88.89% |
Maase (MAAS) | 4/13/2026 - 4/19/2026 | 83.58% |
Avis Budget (CAR) | 4/13/2026 - 4/19/2026 | 71.48% |
Uniqure (QURE) | 6/15/2026 - 6/21/2026 | 66.81% |
Applied Opt (AAOI) | 2/23/2026 - 3/1/2026 | 66.73% |
Liberty Global PLC Class B (LBTYB) | 2/2/2026 - 2/8/2026 | 66.14% |
Enliven Therapeutics (ELVN) | 1/5/2026 - 1/11/2026 | 65.71% |
Avis Budget (CAR) | 4/6/2026 - 4/12/2026 | 64.08% |
IONQ (IONQ) | 4/13/2026 - 4/19/2026 | 63.12% |
Kodiak Sciences (KOD) | 3/23/2026 - 3/29/2026 | 62.64% |
Kailera Therapeutics, Inc Common Stock (KLRA) | 4/13/2026 - 4/19/2026 | 62.5% |
Ziff Davis (ZD) | 3/2/2026 - 3/8/2026 | 61.34% |
Palvella Therapeutics (PVLA) | 2/23/2026 - 3/1/2026 | 58.49% |
Sterling Infrastructure (STRL) | 5/4/2026 - 5/10/2026 | 57.07% |